Parcell Laboratories, the research arm of the Parcell Group of biotechnology companies, was founded in 2008 explicitly to explore the potential applications of a newly discovered line of stem cells called early lineage adult (ELA) stem cells. Headed by Pamela Layton and based in Natick, Massachusetts, Parcell Laboratories partners with Harvard-based researchers in regenerative medicine to identify optimal therapeutic areas for the ELA line. Positive study results in spinal surgery patients continue to spur product development and business affiliations with biotechnology storage and distribution companies. Future goals include expansion of allogeneic ELA capabilities in broad therapeutic areas beyond joint and spinal treatment.

Company Background

Chief executive officer Pamela Layton cofounded Parcell Laboratories and its affiliated companies shortly after the discovery of ELA cells at Brigham and Women’s ...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles